Skip to main content
Top
Published in: Rheumatology International 11/2013

01-11-2013 | Original Article

Gout: a critical analysis of scientific development

Authors: Alexander Gerber, David A. Groneberg, Doris Klingelhöfer, Matthias Bundschuh

Published in: Rheumatology International | Issue 11/2013

Login to get access

Abstract

In recent years, scientific efforts on the topic “gout” have focused on pathogenetic aspects. This has opened new strategies of anti-inflammatory therapy and has improved urate-lowering therapy. So far, a scientometric analysis of the topic “gout” has not been generated despite an increased need for it in times of modified evaluation criteria for academic personnel and a subsequent tendency to co-authorship and author self-citation. The study aims to evaluate quality and quantity of scientific research dealing with the topic “gout” and to contribute to distinguish relevant research output. The current study uses scientometric methods and large-scale data analysis to evaluate quality and quantity of scientific efforts in the field of “gout.” Data were gained from PubMed and ISI-Web. In the last 22 years (1990–2012), 4,424 items were published by 71 countries, of which the USA have been the most productive supplier with 32 % of all publications, followed in considerable distance by the United Kingdom, Japan, Spain and Germany, respectively. The USA have established their position as center of international cooperation. The most prolific journals in the field of gout were “Arthritis and Rheumatism,” “Annals of the Rheumatic diseases” and the “Journal of Rheumatology.” Our analysis specifies the most productive authors and institutions engaged with the topic, the most successful international and national cooperation and the most prolific journals and subject areas. Nevertheless, scientometric indicators, such as h-index, citation rate and impact factor, commonly used for assessment of scientific quality, should be seen critically due to distortion by bias of self-citation and co-authorship.
Literature
1.
go back to reference Andersen J, Belmont J, Cho CT (2006) Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect 39:436–443PubMed Andersen J, Belmont J, Cho CT (2006) Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect 39:436–443PubMed
2.
go back to reference Bartneck C, Kokkelmans S (2011) Detecting h-index manipulation through self-citation analysis. Scientometrics 87:85–98PubMedCrossRef Bartneck C, Kokkelmans S (2011) Detecting h-index manipulation through self-citation analysis. Scientometrics 87:85–98PubMedCrossRef
3.
4.
go back to reference Choi H (2008) Primer on the rheumatic diseases: gout epidemiology, pathology and pathogenesis. Springer Science and Business Media LLC, New York, USA Choi H (2008) Primer on the rheumatic diseases: gout epidemiology, pathology and pathogenesis. Springer Science and Business Media LLC, New York, USA
5.
go back to reference Choi HK, Curhan G (2007) Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 57:816–821PubMedCrossRef Choi HK, Curhan G (2007) Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 57:816–821PubMedCrossRef
7.
8.
go back to reference Gastner MT, Newman ME (2004) From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci USA 101:7499–7504PubMedCrossRef Gastner MT, Newman ME (2004) From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci USA 101:7499–7504PubMedCrossRef
9.
go back to reference Hak AE, Choi HK (2008) Menopause, postmenopausal hormone use and serum uric acid levels in US women—the third national health and nutrition examination survey. Arthritis Res Ther 10:R116PubMedCrossRef Hak AE, Choi HK (2008) Menopause, postmenopausal hormone use and serum uric acid levels in US women—the third national health and nutrition examination survey. Arthritis Res Ther 10:R116PubMedCrossRef
10.
go back to reference Haug C (2006) Authorship and co-authorship. Tidsskr Nor Laegeforen 126:429PubMed Haug C (2006) Authorship and co-authorship. Tidsskr Nor Laegeforen 126:429PubMed
11.
12.
go back to reference Hirsch JE (2005) An index to quantify an individual’s scientific research output. Proc Natl Acad Sci USA 102:16569–16572PubMedCrossRef Hirsch JE (2005) An index to quantify an individual’s scientific research output. Proc Natl Acad Sci USA 102:16569–16572PubMedCrossRef
13.
go back to reference Kulkarni AV, Aziz B, Shams I et al (2011) Author self-citation in the general medicine literature. PLoS One 6:e20885PubMedCrossRef Kulkarni AV, Aziz B, Shams I et al (2011) Author self-citation in the general medicine literature. PLoS One 6:e20885PubMedCrossRef
14.
go back to reference Man CY, Cheung IT, Cameron PA et al (2007) Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 49:670–677PubMedCrossRef Man CY, Cheung IT, Cameron PA et al (2007) Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 49:670–677PubMedCrossRef
15.
go back to reference Martinon F, Petrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241PubMedCrossRef Martinon F, Petrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241PubMedCrossRef
16.
go back to reference Mohebbi MR (2008) The impact of “Impact Factor” on medical journalism in the developing world! Indian Pediatr 45:604PubMed Mohebbi MR (2008) The impact of “Impact Factor” on medical journalism in the developing world! Indian Pediatr 45:604PubMed
17.
go back to reference Onuora S (2012) Crystal arthritis: canakinumab relieves gout flares when treatment options are limited. Nat Rev Rheumatol 8:369PubMedCrossRef Onuora S (2012) Crystal arthritis: canakinumab relieves gout flares when treatment options are limited. Nat Rev Rheumatol 8:369PubMedCrossRef
18.
go back to reference Petrilli V, Martinon F (2007) The inflammasome, autoinflammatory diseases, and gout. Jt Bone Spine 74:571–576CrossRef Petrilli V, Martinon F (2007) The inflammasome, autoinflammatory diseases, and gout. Jt Bone Spine 74:571–576CrossRef
20.
go back to reference Saag KG, Choi H (2006) Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 8(Suppl 1):S2PubMedCrossRef Saag KG, Choi H (2006) Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 8(Suppl 1):S2PubMedCrossRef
21.
go back to reference Sundy JS, Baraf HS, Yood RA et al (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306:711–720PubMedCrossRef Sundy JS, Baraf HS, Yood RA et al (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306:711–720PubMedCrossRef
22.
go back to reference Terkeltaub R (2010) Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 6:30–38PubMedCrossRef Terkeltaub R (2010) Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 6:30–38PubMedCrossRef
23.
go back to reference Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324PubMedCrossRef Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324PubMedCrossRef
24.
go back to reference Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301–1311PubMedCrossRef Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301–1311PubMedCrossRef
Metadata
Title
Gout: a critical analysis of scientific development
Authors
Alexander Gerber
David A. Groneberg
Doris Klingelhöfer
Matthias Bundschuh
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2805-1

Other articles of this Issue 11/2013

Rheumatology International 11/2013 Go to the issue